In the latest trading session,, 6.28 million Pfizer Inc. (NYSE:PFE) shares changed hands as the company’s beta touched 0.66. With the company’s most recent per share price at $27.20 changing hands around $0.22 or 0.83% at last look, the market valuation stands at $154.15B. PFE’s current price is a discount, trading about -46.58% off its 52-week high of $39.87. The share price had its 52-week low at $25.20, which suggests the last value was 7.35% up since then. When we look at Pfizer Inc.’s average trading volume, we note the 3-month average coming to 38.04 million.
Pfizer Inc. (NYSE:PFE) trade information
Instantly PFE is in green as seen in intraday trades today. With action -2.95%, the performance over the past five days has been red. The jump to weekly highs of 28.23 added 0.83% to the stock’s daily price. The company’s shares are showing year-to-date downside of -5.51%, with the 5-day performance at -2.95% in the red. However, in the 30-day time frame, Pfizer Inc. (NYSE:PFE) is -5.02% down.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pfizer Inc. (PFE) estimates and forecasts
Data shows that the Pfizer Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 2.15% over the past 6 months, a 29.35% in annual growth rate that is considerably higher than the industry average of 5.40%. Year-over-year growth is forecast to reach 3.60% up from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 13.04B. 13 analysts are of the opinion that Pfizer Inc.’s revenue for the current quarter will be 14.8B. The company’s revenue for the corresponding quarters a year ago was 12.73B and 13.23B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 2.40%. The estimates for the next quarter sales put growth at 11.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -27.43%. The 2024 estimates are for Pfizer Inc. earnings to increase by 27.63%, but the outlook for the next 5-year period is at 14.03% per year.
PFE Dividends
Pfizer Inc. is expected to release its next quarterly earnings report in July. The 6.10% annual yield figure for the share gives it an annual dividend of 1.66. It is important to note, however, that the 6.10% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
